Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Minimally modified low-density lipoprotein upregulates the ETB and α1 receptors in mouse mesenteric arteries in vivo by activating the PI3K/Akt pathway.

Zeng ZS, Lin J, Xu CB, Cao L, Chen C, Li J.

J Pharm Pharmacol. 2019 Jun;71(6):937-944. doi: 10.1111/jphp.13069. Epub 2019 Jan 20.

PMID:
30663067
2.

Curcumin Exerts Effects on the Pathophysiology of Alzheimer's Disease by Regulating PI(3,5)P2 and Transient Receptor Potential Mucolipin-1 Expression.

Zhang L, Fang Y, Cheng X, Lian YJ, Xu HL, Zeng ZS, Zhu HC.

Front Neurol. 2017 Oct 9;8:531. doi: 10.3389/fneur.2017.00531. eCollection 2017. Retraction in: Front Neurol. 2019 Feb 27;10:255.

3.

Antepartum embolization in management of labor induction in placenta previa.

Huang LL, Tang H, Awale R, Zeng ZS, Li FR, Chen Y.

Clin Exp Obstet Gynecol. 2013;40(3):454-6.

PMID:
24283189
4.

[A study on paternity testing with 96 autosomal SNPs].

Lee L, Wang L, Feng QC, Zhu YL, Cheng XL, Kong XD, Huang YM, Wang WF, Zeng ZS.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2012 Feb;29(1):28-33. doi: 10.3760/cma.j.issn.1003-9406.2012.01.008. Chinese.

PMID:
22311487
5.

Simvastatin-induced myopathy with concomitant use of cyclosporine: case report.

Yang WH, Zeng ZS, Ren XW, Li YP, Shang WJ, Feng GW, Zhang LR.

Int J Clin Pharmacol Ther. 2011 Dec;49(12):772-7.

PMID:
22122820
6.
7.

Hybrid diarylbenzopyrimidine non-nucleoside reverse transcriptase inhibitors as promising new leads for improved anti-HIV-1 chemotherapy.

Zeng ZS, He QQ, Liang YH, Feng XQ, Chen FE, De Clercq E, Balzarini J, Pannecouque C.

Bioorg Med Chem. 2010 Jul 15;18(14):5039-47. doi: 10.1016/j.bmc.2010.05.081. Epub 2010 Jun 4.

PMID:
20598556
8.

Synthesis and anti-HIV activity of 2-naphthyl substituted DAPY analogues as non-nucleoside reverse transcriptase inhibitors.

Liang YH, He QQ, Zeng ZS, Liu ZQ, Feng XQ, Chen FE, Balzarini J, Pannecouque C, Clercq ED.

Bioorg Med Chem. 2010 Jul 1;18(13):4601-5. doi: 10.1016/j.bmc.2010.05.036. Epub 2010 May 20.

PMID:
20570527
9.

Lead optimization of diarylpyrimidines as non-nucleoside inhibitors of HIV-1 reverse transcriptase.

Zeng ZS, Liang YH, Feng XQ, Chen FE, Pannecouque C, Balzarini J, De Clercq E.

ChemMedChem. 2010 Jun 7;5(6):837-40. doi: 10.1002/cmdc.201000045. No abstract available.

PMID:
20333620
10.

Synthesis and biological evaluation of 4-(hydroxyimino)arylmethyl diarylpyrimidine analogues as potential non-nucleoside reverse transcriptase inhibitors against HIV.

Feng XQ, Zeng ZS, Liang YH, Chen FE, Pannecouque C, Balzarini J, De Clercq E.

Bioorg Med Chem. 2010 Apr 1;18(7):2370-4. doi: 10.1016/j.bmc.2010.03.007. Epub 2010 Mar 9.

PMID:
20307984
11.

KRAS mutation and microsatellite instability: two genetic markers of early tumor development that influence the prognosis of colorectal cancer.

Nash GM, Gimbel M, Cohen AM, Zeng ZS, Ndubuisi MI, Nathanson DR, Ott J, Barany F, Paty PB.

Ann Surg Oncol. 2010 Feb;17(2):416-24. doi: 10.1245/s10434-009-0713-0. Epub 2009 Oct 8.

12.

KRAS mutation correlates with accelerated metastatic progression in patients with colorectal liver metastases.

Nash GM, Gimbel M, Shia J, Nathanson DR, Ndubuisi MI, Zeng ZS, Kemeny N, Paty PB.

Ann Surg Oncol. 2010 Feb;17(2):572-8. doi: 10.1245/s10434-009-0605-3. Epub 2009 Sep 1.

PMID:
19727962
13.

Design, synthesis, and SAR of naphthyl-substituted Diarylpyrimidines as non-nucleoside inhibitors of HIV-1 reverse transcriptase.

Liang YH, Feng XQ, Zeng ZS, Chen FE, Balzarini J, Pannecouque C, De Clercq E.

ChemMedChem. 2009 Sep;4(9):1537-45. doi: 10.1002/cmdc.200900212.

PMID:
19591191
14.

Structural modifications of DAPY analogues with potent anti-HIV-1 activity.

Feng XQ, Liang YH, Zeng ZS, Chen FE, Balzarini J, Pannecouque C, De Clercq E.

ChemMedChem. 2009 Feb;4(2):219-24. doi: 10.1002/cmdc.200800334.

PMID:
19090525
15.

c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases.

Zeng ZS, Weiser MR, Kuntz E, Chen CT, Khan SA, Forslund A, Nash GM, Gimbel M, Yamaguchi Y, Culliford AT 4th, D'Alessio M, Barany F, Paty PB.

Cancer Lett. 2008 Jul 8;265(2):258-69. doi: 10.1016/j.canlet.2008.02.049. Epub 2008 Apr 18.

16.

Population genetic data of 15 STR loci in Han population of Henan province (central China).

Zeng ZS, Zheng XD, Zhu YL, Wang ZQ, Xiang ZD, Meng XS, Wang TP, Dong ZM.

Leg Med (Tokyo). 2007 Jan;9(1):30-2. Epub 2006 Dec 5.

PMID:
17150403
17.

[A PCR-RFLP analysis to HLA-B gene among Chinese northern Han populations].

Zeng ZS, Ding M, Zhu YL, Liu ZF, Sun ZG, Huang HW.

Fa Yi Xue Za Zhi. 2006 Jun;22(3):193-5. Chinese.

PMID:
16856341
18.

[Progress in Attractin(mahogany/ATRN) gene].

Zeng ZS, Yang SL, Wu XL, Shi QS, Liu XC, Ouyang XX.

Yi Chuan. 2003 Nov;25(6):721-4. Chinese.

PMID:
15639969
19.

[Genetic linkage between Atrn gene and microsatellite markers and the effects to some economic traits in pigs].

Zeng ZS, Yang SL, Shi QS, Wu XL, Peng YL, Zuo JB.

Yi Chuan Xue Bao. 2004 Dec;31(12):1375-80. Chinese.

PMID:
15633643
20.

[Clinical analysis of acute coronary infarction patients with roughly normal coronary arteriographic findings].

Zeng ZS, Li ZH, Yi WM, Long J.

Di Yi Jun Yi Da Xue Xue Bao. 2004 Jul;24(7):834-5. Chinese.

PMID:
15257919
21.

Progress in searching for susceptibility gene for inflammatory bowel disease by positional cloning.

Zheng CQ, Hu GZ, Zeng ZS, Lin LJ, Gu GG.

World J Gastroenterol. 2003 Aug;9(8):1646-56. Review.

22.

Automated, multiplex assay for high-frequency microsatellite instability in colorectal cancer.

Nash GM, Gimbel M, Shia J, Culliford AT, Nathanson DR, Ndubuisi M, Yamaguchi Y, Zeng ZS, Barany F, Paty PB.

J Clin Oncol. 2003 Aug 15;21(16):3105-12.

PMID:
12915601
23.

HER 2/neu expression and gene amplification in colon cancer.

Nathanson DR, Culliford AT 4th, Shia J, Chen B, D'Alessio M, Zeng ZS, Nash GM, Gerald W, Barany F, Paty PB.

Int J Cancer. 2003 Jul 20;105(6):796-802.

25.

Metastatic and non-metastatic colorectal cancer (CRC) cells induce host metalloproteinase production in vivo.

Mc Donnell S, Chaudhry V, Mansilla-Soto J, Zeng ZS, Shu WP, Guillem JG.

Clin Exp Metastasis. 1999 Jun;17(4):341-9.

PMID:
10545021
27.
28.

Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9.

Zeng ZS, Huang Y, Cohen AM, Guillem JG.

J Clin Oncol. 1996 Dec;14(12):3133-40.

PMID:
8955659
29.
31.

Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases.

Zeng ZS, Cohen AM, Zhang ZF, Stetler-Stevenson W, Guillem JG.

Clin Cancer Res. 1995 Aug;1(8):899-906.

32.

High levels of transforming growth factor beta 1 correlate with disease progression in human colon cancer.

Friedman E, Gold LI, Klimstra D, Zeng ZS, Winawer S, Cohen A.

Cancer Epidemiol Biomarkers Prev. 1995 Jul-Aug;4(5):549-54.

33.

Toxicity study of hepatic artery infusion chemotherapy with massive dose FUDR in rats.

Zeng ZS, Zhang ZF, Sigurdson ER.

Surg Oncol. 1995 Jun;4(3):147-55.

PMID:
7582187
34.

Family history of cancer, body weight, and p53 nuclear overexpression in Duke's C colorectal cancer.

Zhang ZF, Zeng ZS, Sarkis AS, Klimstra DS, Charytonowicz E, Pollack D, Vena J, Guillem J, Marshall JR, Cordon-Cardo C, et al.

Br J Cancer. 1995 Apr;71(4):888-93.

35.

High level of Nm23-H1 gene expression is associated with local colorectal cancer progression not with metastases.

Zeng ZS, Hsu S, Zhang ZF, Cohen AM, Enker WE, Turnbull AA, Guillem JG.

Br J Cancer. 1994 Nov;70(5):1025-30.

36.

p53 nuclear overexpression: an independent predictor of survival in lymph node--positive colorectal cancer patients.

Zeng ZS, Sarkis AS, Zhang ZF, Klimstra DS, Charytonowicz E, Guillem JG, Cordon-Cardo C, Cohen AM.

J Clin Oncol. 1994 Oct;12(10):2043-50.

PMID:
7931472
37.

Cholecystectomy and colorectal cancer in China.

Zeng ZS, Zhang ZF.

Surg Oncol. 1993 Dec;2(6):311-9.

PMID:
8130937

Supplemental Content

Support Center